The dose-dependent decrease in apoC-III seems to partially explain the reduction in triglycerides following tirzepatide treatment, independently of weight loss
Annual cost matters more than first-month cost
Previous studies have reported inconsistent results when comparing oral, sublingual, and intramuscular administration, often limited by small sample sizes or heterogeneous populations (Vidal-Alaball et al., 2006
This is particularly helpful after orthopedic or soft tissue surgery
This article is not a substitute for medical advice, diagnosis, or treatment
548 Additionally, a medication review to adjust or discontinue medications that may impair cognition or balance is recommended to decrease fall risk